Fertility and Sterility
Volume 91, Issue 4 , Pages 1012-1017, April 2009

Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation

  • Kevin J. Doody, M.D.

      Affiliations

    • Center for Assisted Reproduction, Bedford, Texas
    • ,
  • Vicki L. Schnell, M.D.

      Affiliations

    • Center of Reproductive Medicine, Webster, Texas
    • ,
  • Russell A. Foulk, M.D.

      Affiliations

    • Nevada Center for Reproductive Medicine, Reno, Nevada
    • ,
  • Charles E. Miller, M.D.

      Affiliations

    • Charles Miller & Associates, Arlington Heights, Illinois
    • ,
  • Bradford A. Kolb, M.D.

      Affiliations

    • Huntington Reproductive Center, Pasadena, California
    • ,
  • Emily J. Blake, M.D.

      Affiliations

    • Ferring Pharmaceuticals, Inc., Parsippany, New Jersey
    • Corresponding Author InformationReprint requests: Emily J. Blake, M.D., Ferring Pharmaceuticals, Inc., 4 Gatehall Drive, 3rd Floor, Parsippany, NJ 07054 (FAX: 973-796-1663).
    • ,
  • Vladimir I. Yankov, M.D.

      Affiliations

    • Ferring Pharmaceuticals, Inc., Parsippany, New Jersey

Received 25 November 2007; received in revised form 17 January 2008; accepted 17 January 2008. published online 27 March 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 E.J.B. and V.I.Y are employees of Ferring Pharmaceuticals. C.E.M. receives grant support from Ferring Pharmaceuticals, acts as a consultant for Ferring Pharmaceuticals, Ethicon Endo Surgery, Ethicon Women's Health and Urology, Smith & Nephew, Galil Medical, and Boston Scientific, and serves on speakers bureaus for Boston Scientific, Ferring Pharmaceuticals, Ethicon Endo Surgery, and Ethicon Women's Health and Urology. K.J.D. has nothing to disclose. V.L.S. has nothing to disclose. R.A.F. has nothing to disclose. B.A.K. has nothing to disclose.

 Endometrin, Menopur, Bravelle: Ferring Pharmaceuticals, Parsippany, NJ.

PII: S0015-0282(08)00163-5

doi:10.1016/j.fertnstert.2008.01.069

Fertility and Sterility
Volume 91, Issue 4 , Pages 1012-1017, April 2009

Article Tools